To a degree, yes. I have posted that I believe that EDE can progress despite what I believe is poor management decisions. The move into Korea is the key that will start some sales and maybe encourage a move towards Australian sales. Unless there is news that the trials in the USA are failing then it does show there is a saleable product. I have never liked the company structure and I am not alone on that point. I have not criticised the product.
Management is not dumb. They just haven't been good managers in my eyes. They have had a wake up call.
- Forums
- ASX - By Stock
- EDE
- Options strategy.
Options strategy., page-19
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EDE (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.216M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
EDE (ASX) Chart |
Day chart unavailable